Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Law firm investigates ADMA Biologics over alleged revenue inflation and stock drop.
ADMA
$8.78
-$0.09 -1.01%

Law firm investigates ADMA Biologics over alleged revenue inflation and stock drop.

Market News
08 Apr 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Bragar Eagel & Squire, P.C. is investigating ADMA Biologics following a report accusing the company of inflating revenue through channel stuffing and undisclosed related party dealings. The report led to a 16.63% drop in ADMA's stock price on March 24, 2026. The law firm encourages affected investors to contact them to discuss potential legal claims regarding securities law violations. There is no cost or obligation for investors seeking more information or wishing to participate in the investigation.

More News (ADMA)

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Deadline nears for investors to join class action lawsuits against BTGO, VIA, Z, and ADMA for alleged securities fraud.

Law Offices of Howard G. Smith reminds investors of approaching deadlines to file lead plaintiff motions in class action lawsuits against BitGo Holdings, Via Transportation, Zillow Group, and ADMA Biologics. These lawsuits allege the companies made f...

Market News
Bearish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App